[New viewpoints on the effect of beta-receptor blockaders].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000526:Alprenolol / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000097:blood*; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000097:blood; D005082:Physical Exertion; D011217:Practolol / Q000008:administration & dosage; D014700:Verapamil / Q000008:administration & dosage
D000319:Adrenergic beta-Antagonists; D000526:Alprenolol; D014700:Verapamil; D011217:Practolol; D009638:Norepinephrine
Neue Gesichtspunkte zur Wirkung der beta-Rezeptorenblocker.